Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma

Journal of Surgical Oncology

Volumn 106, Issue 2, 2012, Pages 188-192

  Kurashige, Junji ^a   Kamohara, Hidenobu ^a   Watanabe, Masayuki ^a   Tanaka, Youhei ^a   Kinoshita, Koichi ^a   Saito, Seiya ^a   Hiyoshi, Yukiharu ^a   Iwatsuki, Masaaki ^a   Baba, Yoshifumi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

ESCC; micoRNA; Serum

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; MICRORNA 21;

AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84863715591     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23064     Document Type: Article

References (32)

1. Ruol A, Castoro C, Portale G, et al.: Trends in management and prognosis for esophageal cancer surgery: Twenty-five years of experience at a single institution. Arch Surg 2009; 144: 247-254, discussion 254.
2. Morita M, Yoshida R, Ikeda K, et al.: Advances in esophageal cancer surgery in Japan: An analysis of 1000 consecutive patients treated at a single institute. Surgery 2008; 143: 499-508.
3. Ambros V:, The functions of animal microRNAs. Nature 2004; 431: 350-355. (Pubitemid 39265675)
4. Zamore PD, Haley B:, Ribo-gnome: The big world of small RNAs. Science 2005; 309: 1519-1524. (Pubitemid 41266468)
5. Meister G:, miRNAs get an early start on translational silencing. Cell 2007; 131: 25-28. (Pubitemid 47498539)
6. Calin GA, Liu CG, Sevignani C, et al.: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004; 101: 11755-11760. (Pubitemid 39095368)
7. Iorio MV, Ferracin M, Liu CG, et al.: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-7070. (Pubitemid 41161233)
8. Murakami Y, Yasuda T, Saigo K, et al.: Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25: 2537-2545.
9. Yanaihara N, Caplen N, Bowman E, et al.: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198. (Pubitemid 43357945)
10. Guo Y, Chen Z, Zhang L, et al.: Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33. (Pubitemid 351380102)
11. Luthra R, Singh RR, Luthra MG, et al.: MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008; 27: 6667-6678.
12. Mathe EA, Nguyen GH, Bowman ED, et al.: MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: Associations with survival. Clin Cancer Res 2009; 15: 6192-6200.
13. Hiyoshi Y, Kamohara H, Karashima R, et al.: MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 2009; 15: 1915-1922.
14. Volinia S, Calin GA, Liu CG, et al.: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261. (Pubitemid 43271657)
15. Tran N, McLean T, Zhang X, et al.: MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 2007; 358: 12-17. (Pubitemid 46722705)
16. Meng F, Henson R, Wehbe-Janek H, et al.: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-658. (Pubitemid 47187346)
17. Zhu S, Wu H, Wu F, et al.: MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008; 18: 350-359. (Pubitemid 351333899)
18. Zhu S, Si ML, Wu H, et al.: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282: 14328-14336. (Pubitemid 47100416)
19. Tsui NB, Ng EK, Lo YM:, Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 2002; 48: 1647-1653.
20. El-Hefnawy T, Raja S, Kelly L, et al.: Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 2004; 50: 564-573. (Pubitemid 38297307)
21. Lawrie CH, Gal S, Dunlop HM, et al.: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-675. (Pubitemid 351667616)
22. Mitchell PS, Parkin RK, Kroh EM, et al.: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
23. Watanabe M, Nagai Y, Kinoshita K, et al.: Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer. Digestion 2011; 83: 146-152.
24. Kroh EM, Parkin RK, Mitchell PS, et al.: Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010; 50: 298-301.
25. Huang Z, Huang D, Ni S, et al.: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127: 118-126.
26. Chen X, Ba Y, Ma L, et al.: Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
27. Yamamoto Y, Kosaka N, Tanaka M, et al.: MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 2009; 14: 529-538.
28. Wong TS, Liu XB, Wong BY, et al.: Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008; 14: 2588-2592.
29. Lawrie CH, Chi J, Taylor S, et al.: Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med 2009; 13: 1248-1260.
30. Wang J, Chen J, Chang P, et al.: MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (PhilaPa) 2009; 2: 807-813.
31. Resnick KE, Alder H, Hagan JP, et al.: The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112: 55-59.
32. Tsujiura M, Ichikawa D, Komatsu S, et al.: Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010; 102: 1174-1179.